FRESENIUS MEDICAL CARE AG Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss
FRESENIUS MEDICAL CARE AG (FMS) reported Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss of -EUR 43.79 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-24.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss · last filed 2026-02-24
| Period end | Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss 12 month |
|---|---|
| 2025-12-31 | -43.79M EUR 20-F · filed 2026-02-24 |
| 2024-12-31 | -23.06M EUR 20-F · filed 2026-02-24 |
| 2023-12-31 | -35.50M EUR 20-F · filed 2025-02-25 |
| 2022-12-31 | -32.66M EUR 20-F · filed 2024-02-20 |
| 2021-12-31 | -9.90M EUR 20-F · filed 2023-02-22 |
| 2020-12-31 | -15.92M EUR 20-F · filed 2022-02-22 |
| 2019-12-31 | -4.90M EUR 20-F · filed 2021-02-23 |
| 2018-12-31 | -21.39M EUR 20-F · filed 2020-02-20 |